Efficacy and safety of sertaconazole in the treatment of dermatophytoses
DOI:
https://doi.org/10.66344/jpad.v31i1.1702Abstract
Background Dermatophytoses are becoming increasingly unresponsive to topical conventional antifungals now a days. Sertaconazole is a new, broad spectrum, fungicidal and fungistatic imidazole with added antipruritic and anti-inflammatory activity that may be beneficial in efficacy and improving the quality of life for patients with dermatophytoses.
Objective To assess the efficacy and safety of topical sertaconazole cream in the treatment of localized tinea corporis and tinea cruris.
Methods A prospective, clinical trial was conducted with 81 cases of dermatophytosis patients attending outpatient department (OPD) of Dermatology and Venereology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh. Patients were advised to apply sertaconazole cream 2 times per day for 4 weeks and patients were followed up for clinical improvement and side-effects of drug therapy.
Results The improvement of clinical score was from baseline to 41.6% at week 1; 89.3% at week 2 and 91.5% at week 4. On the basis of global response, level of improvement was clear in 55 (67.9%) patients, good in 25 (30.9%) patients and fair in 55 (67.9%) patients. Based on clinical efficacy, cure was observed in 55 (67.9%) patients, improvement in 25 (30.9%) patients and failure in 1 (1.2%) patients. About 78(96.3%) patients didn’t suffer from any side effects from application of sertaconazole cream.
Conclusion On the basis of the results, it can be concluded that sertaconazole can be considered effective and a safe drug for the treatment of dermatophytosis.
References
1. Niewerth M, Korting HC. The use of systemic antimycotics in dermatotherapy. Eur J Dermatol. 2000;10:155–60.
2. Pakshir K, Hashemi J. Dermatophytosis in Karaj, Iran. Indian J Dermatol. 2006;51:262–4.
3. Das S, Barbhuniya JN, Biswas I, Bhattacharya S, Kundu PK. Studies on comparison of the efficacy of terbinafine 1% cream and butenafine 1% cream for the treatment of Tinea cruris. Indian Dermatol Online J. 2010;1:8–9.
4. Jerajani H, Janaki C, Kumar S, Phiske M. Comparative assessment of the efficacy and safety of sertaconazole (2%) cream versus terbinafine cream (1%) versus luliconazole (1%) cream in patients with dermatophytoses: A pilot study. Indian J Dermatol. 2013;58:34–8.
5. Thomas B. Clear choices in managing epidermal tinea infections. J Fam Pract. 2003;52:850–62.
6. Sud IJ, Feingold DS. Mechanisms of action of the antimycotic imidazoles. J Invest Dermatol. 1981;76:438–41.
7. Suschka S, Fladung B, Merk HF. Clinical comparison of the efficacy and tolerability of once daily canesten with twice daily nizoral (clotrimazole1% cream vs. ketoconazole 2% cream) during a 28-day topical treatment of interdigital tinea pedis. Mycoses. 2002;45:91–6.
8. Croxtall JD, Plosker GL. Sertaconazole: A review of its use in the management of superficial mycoses in dermatology and gynaecology. Drugs. 2009;69:339–59.
9. Das A, Sil A, Sarkar TK, Sen A, Chakravorty S, Sengupta M, Das A, Chandra S, Pal S, Bandyopadhyay D, Das NK. A randomized, double-blind trial of amorolfine 0.25% cream and sertaconazole 2% cream in limited dermatophytosis. Indian J Dermatol Venereol Leprol. 2019;85(3):276-81.
doi: 10.4103/ijdvl.IJDVL_907_17.
10. Thaker SJ1, Mehta DS, Shah HA, Dave JN, Mundhava SG. A comparative randomized open label study to evaluate efficacy, safety and cost effectiveness between topical 2% sertaconazole and topical 1% butenafine in tinea infections of skin. Indian J Dermatol. 2013;58(6):451-6.
doi: 10.4103/0019-5154.119955.
11. Liebel F, Lyte P, Garay M, Babad J, Southall MD. Anti-inflammatory and anti-itch activity of sertaconazole nitrate. Arch Dermatol Res. 2006;298:191–9.
12. Carrillo-Muñoz AJ, Fernández-Torres B, Cárdenes DC, Guarro J. In vitro activity of sertaconazole against dermatophyte isolates with reduced fluconazole susceptibility. Chemotherapy. 2003;49:248–51.
13. Sharma A, Saple DG, Surjushe A, Rao GR, Kura M, Ghosh S, et al. Efficacy and tolerability of sertaconazole nitrate 2% cream vs. miconazole in patients with cutaneous dermatophytosis. Mycoses. 2011;54:217–22.
14. Goldust M, Rezaee E, Rouhani S. Double blind study of sertaconazole 2% cream vs. clotrimazole 1% cream in treatment of seborrheic dermatitis. Ann Parasitol. 2013;59:25–9.
15. Palacín C1, Tarragó C, Ortiz JA. Sertaconazole: pharmacology of a gynecological antifungal agent. Int J Gynaecol Obstet. 2000;71:S37-46.
16. Choudhary SV, Bisate S, Singh A, Koley S. Efficacy and safety of terbinafine hydrochloride 1% cream versus sertaconazole nitrate 2% cream in tinea corporis and tinea cruris: A comparative therapeutic trial. Indian J Dermatol. 2013;58:457–60.
17. Chatterjee D, Ghosh SK, Sen S, Sarkar S, Hazra A, and De R. Efficacy and tolerability of topical sertaconazole versus topical terbinafine in localized dermatophytosis: A randomized, observer-blind, parallel group study. Indian J Pharmacol. 2016;48(6):659–64.
doi: 10.4103/0253-7613.194850
18. Romaguera C, Herrero E, Márquez M, Torres J, Ortiz JA. Study on the sensitizing capacity of the new antimycotic sertaconazole in the treatment of cutaneous mycoses. Arzneimittelforschung. 1992;42(5A):754-6.
19. Alomar C, Bassas S, Casas M, Crespo V, Ferrándiz C, Fonseca E et al. Multi-centre double-blind trial on the efficacy and safety of sertaconazole 2% cream in comparison with miconazole 2% cream on patients suffering from cutaneous mycoses. Arzneimittelforschung. 1992;42(5A):767-73.
20. Shivamurthy RP1, Reddy SG2, Kallappa R2, Somashekar SA2, Patil D2, Patil UN2. Comparison of topical anti- fungal agents sertaconazole and clotrimazole in the treatment of tinea corporis-an observational study. J Clin Diagn Res. 2014;8(9):HC09-12.
doi: 10.7860/JCDR/2014/10210.4866. Epub 2014 Sep 20.
21. Borelli C1, Klövekorn G, Ernst TM, Bödeker RH, Korting HC, Neumeister C. Comparative study of 2% sertaconazole solution and cream formulations in patients with tinea corporis, tinea pedis interdigitalis, or a corresponding candidosis. Am J Clin Dermatol. 2007;8(6):371-8.
22. Weinberg JM1, Koestenblatt EK. Treatment of interdigital tinea pedis: once-daily therapy with sertaconazole nitrate. J Drugs Dermatol. 2011;10(10):1135-40.
23. Savin R, Jorizzo J. The safety and efficacy of sertaconazole nitrate cream 2% for tinea pedis. Cutis. 2006;78(4):268-74.
24. Borelli C, Korting HC, Bödeker RH, Neumeister C. Safety and efficacy of sertaconazole nitrate cream 2% in the treatment of tinea pedis interdigitalis: a subgroup analysis. Cutis. 2010;85(2):107-11.
25. Esso DV, Fajo G, Losada I, Vilallonga M, Casanovas JM, Clanxet J, et al. Sertaconazole in the treatment of pediatric patients with cutaneous dermatophyte infections. Clin Therap.1995;17:264–9.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Lubna Khondker
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
